In earlier animal trials, the compound demonstrated a great deal of promise in promoting the regrowth of missing teeth; in ferrets, a single dose was enough to regenerate a tooth. The trial’s principal investigators report that the rodents likewise tolerated the new formulation of the medication well, with no negative

The treatment will be given to children with congenital tooth deficiencies if the trial is successful. Patients with at least four missing teeth since birth who are between the ages of two and seven will be the first to get the medication.According to a study released two years ago, teeth could regrow if the USAG-1 gene is inhibited by an antibody therapy. Researchers from the Universities of Fukui and Kyoto discovered that the antibody treatment stimulates tooth growth by targeting the single gene (image).Lead researcher Katsu Takahashi told The Mainichi, “We want to do something to help those who are suffering from tooth loss or absence.” “We believe that people have high expectations for tooth growth, even though there is currently no treatment that offers a permanent cure.”